Results

Publications

• Z. Wang, S. Shaabani, X. Gao, Y. L. D. Ng, V. Sapozhnikova, P. Mertins, J. Krönke and A. Dömling, “Direct-to-biology, automated, nano-scale synthesis, and phenotypic screening-enabled E3 ligase modulator discovery,” NATURE COMMUNICATIONS, vol. 14, iss. 1, 2023.
  DOI: 10.1038/s41467-023-43614-3
• P. Patil, Q. Zheng, K. Kurpiewska and A. Dömling, “The isocyanide SN2 reaction,” NATURE COMMUNICATIONS, vol. 14, iss. 1, 2023.
  DOI: 10.1038/s41467-023-41253-2
• J. Li, A. L. Chandgude, Q. Zheng and A. Dömling, “Innovative synthesis of drug-like molecules using tetrazole as core building blocks,” BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY, vol. 20, pp. 950-958, 2024.
  DOI: 10.3762/bjoc.20.85
• J. Li, Q. Zheng and A. Dömling, “Exploring Phthalimide as the Acid Component in the Passerini Reaction,” ORGANIC LETTERS, vol. 26, iss. 4, pp. 829-833, 2024.
  DOI: 10.1021/acs.orglett.3c03962
• S. Raghuwanshi, X. Zhang, Z. Arbieva, I. Khan, H. Mohammed, Z. Wang, A. Domling, C. J. Camacho and A. L. Gartel, “Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies,” CELL DEATH DISCOVERY, vol. 10, iss. 1, 2024.
  DOI: 10.1038/s41420-024-01929-0
• M. A. Ważyńska, R. Butera, M. Requesens, A. Plat, T. Zarganes-Tzitzikas, C. G. Neochoritis, J. Plewka, L. Skalniak, J. Kocik-Krol, B. Musielak, K. Magiera-Mularz, I. Rodriguez, S. N. Blok, M. de Bruyn, H. W. Nijman, P. H. Elsinga, T. A. Holak and A. Dömling, “Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors,” JOURNAL OF MEDICINAL CHEMISTRY, vol. 66, iss. 14, pp. 9577-9591, 2023.
  DOI: 10.1021/acs.jmedchem.3c00254